PTHS
Price
$16.18
Change
-$0.32 (-1.94%)
Updated
Jul 3 closing price
Capitalization
N/A
61 days until earnings call
SONN
Price
$3.92
Change
-$0.23 (-5.54%)
Updated
Jul 3 closing price
Capitalization
12.41M
Interact to see
Advertisement

PTHS vs SONN

Header iconPTHS vs SONN Comparison
Open Charts PTHS vs SONNBanner chart's image
Pelthos Therapeutics
Price$16.18
Change-$0.32 (-1.94%)
Volume$13.51K
CapitalizationN/A
Sonnet BioTherapeutics Holdings
Price$3.92
Change-$0.23 (-5.54%)
Volume$6.2M
Capitalization12.41M
PTHS vs SONN Comparison Chart in %
Loading...
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTHS vs. SONN commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTHS is a StrongBuy and SONN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (PTHS: $16.18 vs. SONN: $3.92)
Brand notoriety: PTHS and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTHS: 12% vs. SONN: 205%
Market capitalization -- PTHS: $0 vs. SONN: $12.41M
PTHS [@Biotechnology] is valued at $0. SONN’s [@Biotechnology] market capitalization is $12.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTHS’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • PTHS’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, SONN is a better buy in the long-term than PTHS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTHS’s TA Score shows that 5 TA indicator(s) are bullish while SONN’s TA Score has 5 bullish TA indicator(s).

  • PTHS’s TA Score: 5 bullish, 5 bearish.
  • SONN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SONN is a better buy in the short-term than PTHS.

Price Growth

PTHS (@Biotechnology) experienced а +1283.33% price change this week, while SONN (@Biotechnology) price change was +240.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

PTHS is expected to report earnings on Sep 03, 2025.

SONN is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTHS YTD gains are higher at: 2424.961 vs. SONN (168.493).
PTHSSONNPTHS / SONN
CapitalizationN/A12.4M-
EBITDAN/A-13.69M-
Gain YTD2424.961168.4931,439%
P/E RatioN/A0.29-
RevenueN/A1M-
Total CashN/A2.06M-
Total DebtN/A90.4K-
FUNDAMENTALS RATINGS
SONN: Fundamental Ratings
SONN
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PTHSSONN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 15 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 24 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMZE9.370.26
+2.80%
Amaze Holdings Inc
GLSI10.030.15
+1.52%
Greenwich LifeSciences
CTRA25.220.19
+0.76%
Coterra Energy
ANAB23.75-0.13
-0.54%
AnaptysBio
BTU14.50-0.18
-1.23%
Peabody Energy Corp

PTHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTHS has been closely correlated with SONN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTHS jumps, then SONN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTHS
1D Price
Change %
PTHS100%
-1.91%
SONN - PTHS
70%
Closely correlated
-5.54%
LIXT - PTHS
34%
Loosely correlated
+40.10%
MBIO - PTHS
29%
Poorly correlated
-4.03%
ELEV - PTHS
28%
Poorly correlated
+2.46%
CYBN - PTHS
27%
Poorly correlated
+7.59%
More

SONN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONN has been closely correlated with PTHS. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SONN jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-5.54%
PTHS - SONN
70%
Closely correlated
-1.91%
LIXT - SONN
36%
Loosely correlated
+40.10%
NTRB - SONN
29%
Poorly correlated
-7.56%
MCRB - SONN
27%
Poorly correlated
+9.30%
DWTX - SONN
27%
Poorly correlated
-0.62%
More